Terms: = Thyroid cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
28 results:
1. The role of transcription factor foxa1/C2/M1/O3/P1/Q1 in breast cancer.
Yuan H; Liang Y; Hu S; Chen J; You J; Jiang J; Luo M; Zeng M
Medicine (Baltimore); 2024 Apr; 103(15):e37709. PubMed ID: 38608123
[TBL] [Abstract] [Full Text] [Related]
2. Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer.
Iwamoto T; Niikura N; Watanabe K; Takeshita T; Kikawa Y; Kobayashi K; Iwakuma N; Okamura T; Tada H; Ozaki S; Okuno T; Toh U; Yamamoto Y; Tsuneizumi M; Ishiguro H; Masuda N; Saji S
Breast Cancer Res Treat; 2024 Jan; 203(2):225-234. PubMed ID: 37875670
[TBL] [Abstract] [Full Text] [Related]
3. foxa1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast cancer.
Wu Y; Li Z; Wedn AM; Casey AN; Brown D; Rao SV; Omarjee S; Hooda J; Carroll JS; Gertz J; Atkinson JM; Lee AV; Oesterreich S
Mol Cancer Res; 2023 Jun; 21(6):591-604. PubMed ID: 36930833
[TBL] [Abstract] [Full Text] [Related]
4. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC.
Guo Q; Qiu P; Yao Q; Chen J; Lin J
Dis Markers; 2022; 2022():4964793. PubMed ID: 36157217
[TBL] [Abstract] [Full Text] [Related]
5. foxa1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma.
Orstad G; Fort G; Parnell TJ; Jones A; Stubben C; Lohman B; Gillis KL; Orellana W; Tariq R; Klingbeil O; Kaestner K; Vakoc CR; Spike BT; Snyder EL
Dev Cell; 2022 Aug; 57(15):1866-1882.e10. PubMed ID: 35835117
[TBL] [Abstract] [Full Text] [Related]
6. foxa1 of regulatory variant associated with risk of breast cancer through allele-specific enhancer in the Chinese population.
Li B; Cheng X; Zhu Y; Wan H; Lu Z; Cai Y; Li W; Yi P; Liu L; Chang J; Miao X; Tian J; Zhong R
Breast Cancer; 2022 Mar; 29(2):247-259. PubMed ID: 34635981
[TBL] [Abstract] [Full Text] [Related]
7. An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma.
Zewdu R; Mehrabad EM; Ingram K; Fang P; Gillis KL; Camolotto SA; Orstad G; Jones A; Mendoza MC; Spike BT; Snyder EL
Elife; 2021 Apr; 10():. PubMed ID: 33821796
[TBL] [Abstract] [Full Text] [Related]
8. Signification of forkhead box A1 (foxa1) expression in thyroid cancers.
Missaoui N; Chouaibi S; Limam S; Mhamdi N; Zahmoul T; Hamchi H; Mokni M; Hmissa S
J Egypt Natl Canc Inst; 2019 Dec; 31(1):11. PubMed ID: 32372175
[TBL] [Abstract] [Full Text] [Related]
9. Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects.
Osako T; Lee H; Turashvili G; Chiu D; McKinney S; Joosten SEP; Wilkinson D; Nielsen TO; Zwart W; Emerman JT; Eaves CJ; Caldas C; Aparicio S
Nat Cancer; 2020 May; 1(5):518-532. PubMed ID: 35121983
[TBL] [Abstract] [Full Text] [Related]
10. NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast cancer Cells.
Erdős E; Bálint BL
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168782
[TBL] [Abstract] [Full Text] [Related]
11. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/foxa1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract] [Full Text] [Related]
12. Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A.
Duan L; Yang Z; Jiang X; Zhang J; Guo X
Anticancer Drugs; 2019 Sep; 30(8):812-820. PubMed ID: 30882397
[TBL] [Abstract] [Full Text] [Related]
13. foxa1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
Elife; 2018 Nov; 7():. PubMed ID: 30475207
[TBL] [Abstract] [Full Text] [Related]
14. Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.
Huang C; Liu J; Xiong B; Yonemura Y; Yang X
Gene; 2019 Feb; 685():202-210. PubMed ID: 30415009
[TBL] [Abstract] [Full Text] [Related]
15. miR-132 Targets foxa1 and Exerts Tumor-Suppressing Functions in thyroid cancer.
Chen X; Li M; Zhou H; Zhang L
Oncol Res; 2019 Mar; 27(4):431-437. PubMed ID: 29523221
[TBL] [Abstract] [Full Text] [Related]
16. A study of foxa1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract] [Full Text] [Related]
17. miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting foxa1.
Shen SQ; Huang LS; Xiao XL; Zhu XF; Xiong DD; Cao XM; Wei KL; Chen G; Feng ZB
Oncol Rep; 2017 Jul; 38(1):368-376. PubMed ID: 28534958
[TBL] [Abstract] [Full Text] [Related]
18. foxa1 expression affects the proliferation activity of luminal breast cancer stem cell populations.
Tachi K; Shiraishi A; Bando H; Yamashita T; Tsuboi I; Kato T; Hara H; Ohneda O
Cancer Sci; 2016 Mar; 107(3):281-9. PubMed ID: 26708273
[TBL] [Abstract] [Full Text] [Related]
19. Revising the embryonic origin of thyroid C cells in mice and humans.
Johansson E; Andersson L; Örnros J; Carlsson T; Ingeson-Carlsson C; Liang S; Dahlberg J; Jansson S; Parrillo L; Zoppoli P; Barila GO; Altschuler DL; Padula D; Lickert H; Fagman H; Nilsson M
Development; 2015 Oct; 142(20):3519-28. PubMed ID: 26395490
[TBL] [Abstract] [Full Text] [Related]
20. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Snyder EL; Watanabe H; Magendantz M; Hoersch S; Chen TA; Wang DG; Crowley D; Whittaker CA; Meyerson M; Kimura S; Jacks T
Mol Cell; 2013 Apr; 50(2):185-99. PubMed ID: 23523371
[TBL] [Abstract] [Full Text] [Related]
[Next]
